New hope for slowing rare, aggressive adrenal tumors

This study is testing whether monthly injections of a drug called lanreotide can help control advanced forms of two rare adrenal gland tumors: pheochromocytoma and paraganglioma. It will enroll about 10 adults whose cancer has spread or cannot be surgically removed, and who have shown recent tumor growth. The main goal is to see if the treatment can slow down or stop the tumors from getting bigger compared to how fast they were growing before treatment.